HK1176384A1 - 用於治療、診斷和監控狼瘡的方法 - Google Patents

用於治療、診斷和監控狼瘡的方法

Info

Publication number
HK1176384A1
HK1176384A1 HK13103618.1A HK13103618A HK1176384A1 HK 1176384 A1 HK1176384 A1 HK 1176384A1 HK 13103618 A HK13103618 A HK 13103618A HK 1176384 A1 HK1176384 A1 HK 1176384A1
Authority
HK
Hong Kong
Prior art keywords
diagnosing
treating
methods
lupus
monitoring
Prior art date
Application number
HK13103618.1A
Other languages
English (en)
Inventor
Timothy W Behrens
Robert R Graham
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of HK1176384A1 publication Critical patent/HK1176384A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
HK13103618.1A 2009-10-07 2013-03-22 用於治療、診斷和監控狼瘡的方法 HK1176384A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27851009P 2009-10-07 2009-10-07
PCT/US2010/051589 WO2011044205A1 (en) 2009-10-07 2010-10-06 Methods for treating, diagnosing, and monitoring lupus

Publications (1)

Publication Number Publication Date
HK1176384A1 true HK1176384A1 (zh) 2013-07-26

Family

ID=43857111

Family Applications (1)

Application Number Title Priority Date Filing Date
HK13103618.1A HK1176384A1 (zh) 2009-10-07 2013-03-22 用於治療、診斷和監控狼瘡的方法

Country Status (10)

Country Link
US (3) US20130034544A1 (zh)
EP (3) EP3219813B1 (zh)
JP (2) JP5937008B2 (zh)
KR (2) KR101953075B1 (zh)
CN (2) CN106929568A (zh)
BR (1) BR112012007778A2 (zh)
CA (1) CA2777055C (zh)
HK (1) HK1176384A1 (zh)
RU (2) RU2596391C2 (zh)
WO (1) WO2011044205A1 (zh)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101953075B1 (ko) * 2009-10-07 2019-02-27 제넨테크, 인크. 루푸스의 치료, 진단 및 모니터링 방법
WO2012031122A2 (en) * 2010-09-03 2012-03-08 Immport Therapeutics, Inc. Methods and compositions for the diagnosis and treatment of cancer and autoimmune disorders
KR20140034529A (ko) 2012-09-12 2014-03-20 삼성전기주식회사 전기 동도금 장치
WO2014058254A1 (ko) * 2012-10-10 2014-04-17 가톨릭대학교 산학협력단 １ｑ２５．１(RABGAP1L) 위치, 6P21.32 (C4) 위치 및 １０ｑ２１．３위치의 ＤＮＡ 복제 수 변이 검출용 프라이머를 포함하는 전신성 홍반성 루푸스 발병 위험도 예측용 조성물
KR101491214B1 (ko) * 2012-10-10 2015-02-06 가톨릭대학교 산학협력단 １ｑ２５．１(RABGAP1L) 위치, 6p21.32 (C4) 위치 및 １０ｑ２１．３위치의 ＤＮＡ 복제 수 변이 검출용 프라이머를 포함하는 전신성 홍반성 루푸스 발병 위험도 예측용 조성물
SG11201606843SA (en) * 2014-03-21 2016-10-28 Agency Science Tech & Res Fusion genes in cancer
KR20190034511A (ko) 2019-03-22 2019-04-02 아주대학교산학협력단 Aimp1을 포함하는 전신 홍반성 루프스 진단용 바이오마커 조성물 및 이를 이용한 전신 홍반성 루프스 진단 방법
US20230054595A1 (en) * 2019-12-18 2023-02-23 The Children's Hospital Of Philadelphia Novel druggable targets for the treatment of inflammatory diseases such as systemic lupus erythematosus (sle) and methods for diagnosis and treatment using the same

Family Cites Families (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4657760A (en) 1979-03-20 1987-04-14 Ortho Pharmaceutical Corporation Methods and compositions using monoclonal antibody to human T cells
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4683203A (en) 1984-04-14 1987-07-28 Redco N.V. Immobilized enzymes, processes for preparing same, and use thereof
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US5206344A (en) 1985-06-26 1993-04-27 Cetus Oncology Corporation Interleukin-2 muteins and polymer conjugation thereof
IE61148B1 (en) 1988-03-10 1994-10-05 Ici Plc Method of detecting nucleotide sequences
GB8823869D0 (en) 1988-10-12 1988-11-16 Medical Res Council Production of antibodies
DE3920358A1 (de) 1989-06-22 1991-01-17 Behringwerke Ag Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung
US5225212A (en) 1989-10-20 1993-07-06 Liposome Technology, Inc. Microreservoir liposome composition and method
EP1690935A3 (en) 1990-01-12 2008-07-30 Abgenix, Inc. Generation of xenogeneic antibodies
US5625126A (en) 1990-08-29 1997-04-29 Genpharm International, Inc. Transgenic non-human animals for producing heterologous antibodies
ES2246502T3 (es) 1990-08-29 2006-02-16 Genpharm International, Inc. Animales no humanos transgenicos capaces de producir anticuerpos heterologos.
US5661016A (en) 1990-08-29 1997-08-26 Genpharm International Inc. Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
US5545806A (en) 1990-08-29 1996-08-13 Genpharm International, Inc. Ransgenic non-human animals for producing heterologous antibodies
US5633425A (en) 1990-08-29 1997-05-27 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
GB9114948D0 (en) 1991-07-11 1991-08-28 Pfizer Ltd Process for preparing sertraline intermediates
EP1709970A1 (en) 1995-04-27 2006-10-11 Abgenix, Inc. Human antibodies against EGFR, derived from immunized xenomice
CA2219486A1 (en) 1995-04-28 1996-10-31 Abgenix, Inc. Human antibodies derived from immunized xenomice
WO1997045559A1 (en) 1996-05-29 1997-12-04 Cornell Research Foundation, Inc. Detection of nucleic acid sequence differences using coupled ligase detection and polymerase chain reactions
CA2722378C (en) 1996-12-03 2015-02-03 Amgen Fremont Inc. Human antibodies that bind tnf.alpha.
AU6534600A (en) * 1999-08-09 2001-03-05 Uab Research Foundation Genetic polymorphism in the il-10 promoter
AU2001265121A1 (en) 2000-05-30 2001-12-11 Applera Corporation Methods for detecting target nucleic acids using coupled ligation and amplification
AU2001286949A1 (en) * 2000-08-29 2002-03-13 Genaissance Pharmaceuticals, Inc. Haplotypes of the bf gene
US6900016B1 (en) 2000-09-08 2005-05-31 Applera Corporation Polymorphisms in known genes associated with inflammatory autoimmune disease, methods of detection and uses thereof
NZ525336A (en) 2000-10-20 2006-03-31 Expression Diagnostics Inc Leukocyte expression profiling
US7205106B1 (en) 2001-07-20 2007-04-17 Roche Molecular Systems, Inc. Association of polymorphisms in IL4-related genes with autoimmune disease
JP2003061677A (ja) 2001-08-28 2003-03-04 Olympus Optical Co Ltd 全身性エリテマトーデスの感受性遺伝子およびその使用
US20030119004A1 (en) 2001-12-05 2003-06-26 Wenz H. Michael Methods for quantitating nucleic acids using coupled ligation and amplification
US7022476B2 (en) 2002-02-26 2006-04-04 New York Society For Ruptured And Crippled Maintaining The Hospital For Special Surgery Human FcγRIIB gene polymorphisms for assessing development of systemic lupus erythematosus and compositions for use thereof
US20050026173A1 (en) * 2003-02-27 2005-02-03 Methexis Genomics, N.V. Genetic diagnosis using multiple sequence variant analysis combined with mass spectrometry
US7811794B2 (en) 2003-03-18 2010-10-12 Celera Corporation Genetic polymorphisms associated with rheumatoid arthritis, methods of detection and uses thereof
WO2005086872A2 (en) 2004-03-10 2005-09-22 Celera, An Applera Corporation Business Ptpn22 polymorphisms in diagnosis and therapy
DE102005003686A1 (de) 2005-01-26 2006-08-03 Rohde & Schwarz Gmbh & Co. Kg Anordnung zum Glätten des einem Verbraucher zugeführten Verbraucherstromes
JP2009502936A (ja) * 2005-07-25 2009-01-29 トルビオン ファーマシューティカルズ， インコーポレイテッド Ｃｄ２０特異的結合分子の単一投与量
EP2327792B9 (en) 2005-08-05 2013-12-18 Genentech, Inc. Methods and compositions for detecting auto-immune disorders
CN101378764A (zh) * 2005-12-09 2009-03-04 贝勒研究院 通过血液白细胞微阵列分析对系统性红斑狼疮的诊断、预后和疾病发展的监测
US20070238094A1 (en) * 2005-12-09 2007-10-11 Baylor Research Institute Diagnosis, prognosis and monitoring of disease progression of systemic lupus erythematosus through blood leukocyte microarray analysis
AU2007227609A1 (en) 2006-03-16 2007-09-27 Genentech, Inc. Methods of treating lupus using CD4 antibodies
CN101443040A (zh) * 2006-03-16 2009-05-27 基因技术股份有限公司 用cd4抗体治疗狼疮的方法
US20070269827A1 (en) 2006-05-18 2007-11-22 Oklahoma Medical Research Foundation Predicting and Diagnosing Patients With Autoimmune Disease
WO2008033239A2 (en) * 2006-09-11 2008-03-20 Applera Genetic polymorphisms associated with psoriasis, methods of detection and uses thereof
US20100322928A1 (en) * 2007-01-19 2010-12-23 Yeda Research And Development Co., Ltd. Methods of diagnosing, monitoring treatment and treating systemic lupus erythematosus (sle)
US7695916B2 (en) * 2007-03-22 2010-04-13 Celera Corporation Genetic polymorphisms associated with coronary events and drug response, methods of detection and uses thereof
KR101729431B1 (ko) 2007-05-21 2017-04-21 제넨테크, 인크. 루푸스를 확인 및 치료하기 위한 방법 및 조성물
WO2009015087A2 (en) * 2007-07-20 2009-01-29 Potentia Pharmaceuticals, Inc. Compositions and methods for treatment of trauma
WO2009065132A1 (en) * 2007-11-16 2009-05-22 Oklahoma Medical Research Foundation Predicting and diagnosing patients with autoimmune disease
US20090307180A1 (en) * 2008-03-19 2009-12-10 Brandon Colby Genetic analysis
DE102008031958A1 (de) 2008-07-07 2010-01-14 Klebchemie M.G. Becker Gmbh & Co. Kg Verfahren zum Laminieren von Hochglanzoberflächen
JP2012503985A (ja) * 2008-09-26 2012-02-16 ジェネンテック， インコーポレイテッド ループスの治療、診断、モニタリング方法
KR101953075B1 (ko) 2009-10-07 2019-02-27 제넨테크, 인크. 루푸스의 치료, 진단 및 모니터링 방법

Also Published As

Publication number Publication date
EP3839068A3 (en) 2021-10-20
JP2017012158A (ja) 2017-01-19
JP2013507127A (ja) 2013-03-04
KR101824744B1 (ko) 2018-03-15
CA2777055A1 (en) 2011-04-14
KR101953075B1 (ko) 2019-02-27
JP6321717B2 (ja) 2018-05-09
RU2016131167A (ru) 2018-12-07
EP3219813B1 (en) 2020-11-18
EP3219813A2 (en) 2017-09-20
CN113025703A (zh) 2021-06-25
BR112012007778A2 (pt) 2020-08-11
EP2486152A4 (en) 2013-05-22
EP3219813A3 (en) 2018-01-10
EP2486152B1 (en) 2017-12-06
RU2012118596A (ru) 2013-11-20
CN102803509A (zh) 2012-11-28
CN106929568A (zh) 2017-07-07
US20160273044A1 (en) 2016-09-22
CA2777055C (en) 2021-04-06
US20130034544A1 (en) 2013-02-07
JP5937008B2 (ja) 2016-06-22
KR20180012344A (ko) 2018-02-05
US10053734B2 (en) 2018-08-21
RU2596391C2 (ru) 2016-09-10
EP3839068A2 (en) 2021-06-23
KR20120100969A (ko) 2012-09-12
WO2011044205A1 (en) 2011-04-14
EP2486152A1 (en) 2012-08-15
US20190211398A1 (en) 2019-07-11

Similar Documents

Publication Publication Date Title
HK1245341A1 (zh) 用於治療、診斷和監控類風濕性關節炎的方法
IL211462A0 (en) Methods for treating, diagnosing, and monitoring lupus
EP2234086A4 (en) DEVICE FOR MONITORING A VEHICLE ENVIRONMENT, PROGRAM FOR MONITORING A VEHICLE ENVIRONMENT AND METHOD FOR MONITORING A VEHICLE ENVIRONMENT
HK1147853A1 (zh) 監控系統和方法
GB0914836D0 (en) Cleaning apparatus and method, and monitoring thereof
HK1179338A1 (zh) 滑動軸承的診斷方法和診斷裝置
EP2453427A4 (en) STATUS DETECTION DEVICE, STATUS RECOGNITION PROCESS AND PROGRAM THEREFOR
EP2477086A4 (en) METHOD FOR ANOMALY IDENTIFICATION AND DIAGNOSIS, APPARATUS FOR ANOMALY IDENTIFICATION AND DIAGNOSIS, AND ANOMALIC DETECTION AND DIAGNOSTIC PROGRAM
GB2469902B (en) Device, system and method
EP2400706A4 (en) METHOD FOR CREATING SEQUENCES AND ASSOCIATED APPARATUS
HK1176384A1 (zh) 用於治療、診斷和監控狼瘡的方法
EP2500889A4 (en) GROWTH TEST DEVICE, METHOD AND PROGRAM
EP2141926A4 (en) VEHICLE PERIPHERAL MONITORING DEVICE, VEHICLE PERIPHERAL MONITORING PROGRAM, AND VEHICLE PERIPHERAL MONITORING METHOD
EP2394153A4 (en) EMISSIONS MONITORING DEVICE, SYSTEM AND METHOD
EP2484285A4 (en) DIAGNOSTIC ASSISTING SYSTEM, DIAGNOSTIC ASSISTING PROGRAM, AND DIAGNOSTIC ASSISTING METHOD
EP2396777A4 (en) IMPROVED SYSTEM AND METHOD FOR MONITORING HAND WASHING
EP2249310A4 (en) PERIPHERAL MONITORING DEVICE AND PERIPHERAL MONITORING METHOD
EP2465092A4 (en) DEVICE FOR MONITORING A VEHICLE ENVIRONMENT
EP2497021A4 (en) SYSTEM AND METHOD FOR CONDITIONAL, COST AND PERIOD ANALYZES
PT2414901T (pt) Sistema e método para monitorizar um sistema integrado
EP2557550A4 (en) DEVICE FOR MONITORING A VEHICLE ENVIRONMENT, METHOD FOR MONITORING A VEHICLE ENVIRONMENT AND VEHICLE DEVICE
EP2434759A4 (en) MONITOR
GB201017389D0 (en) Condition monitoring system
GB2487701B (en) Cost evaluation system, method and program
EP2224743A4 (en) METHOD FOR MONITORING A VEHICLE ENVIRONMENT, VEHICLE AND PROGRAM FOR MONITORING A VEHICLE ENVIRONMENT